EP1569684 - USE OF HMGB FRAGMENTS AS ANTI-INFLAMMATORY AGENTS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 15.05.2009 Database last updated on 26.07.2024 | Most recent event Tooltip | 15.05.2009 | Application deemed to be withdrawn | published on 17.06.2009 [2009/25] | Applicant(s) | For all designated states Critical Therapeutics, Inc. 60 Westview Avenue Lexington, MA 02421 / US | [2005/36] | Inventor(s) | 01 /
NEWMAN, Walter 160 West Newton Street Boston, MA 02118 / US | 02 /
O'KEEFE, Theresa, L. 1 Parkers Lane Waltham, MA 02453 / US | [2007/01] |
Former [2005/36] | 01 /
NEWMAN, Walter 3 Durham Street 3 Boston, MA 02115 / US | ||
02 /
O'KEEFE, Theresa, L. 1 Parkers Lane Waltham, MA 02453 / US | Representative(s) | Snodin, Michael D. Potter Clarkson LLP The Belgrave Centre Talbot Street Nottingham NG1 5GG / GB | [N/P] |
Former [2005/36] | Snodin, Michael D. Eric Potter Clarkson Park View House 58 The Ropewalk Nottingham NG1 5DD / GB | Application number, filing date | 03789973.9 | 20.11.2003 | [2005/36] | WO2003US37507 | Priority number, date | US20020427841P | 20.11.2002 Original published format: US 427841 P | US20020427846P | 20.11.2002 Original published format: US 427846 P | [2005/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004046345 | Date: | 03.06.2004 | Language: | EN | [2004/23] | Type: | A2 Application without search report | No.: | EP1569684 | Date: | 07.09.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.06.2004 takes the place of the publication of the European patent application. | [2005/36] | Search report(s) | International search report - published on: | US | 02.12.2004 | (Supplementary) European search report - dispatched on: | EP | 30.06.2006 | Classification | IPC: | A61K39/00, C07K7/00, A61K38/00 | [2005/36] | CPC: |
C07K14/47 (EP);
A61K38/1709 (EP);
A61P1/04 (EP);
A61P1/18 (EP);
A61P11/00 (EP);
A61P11/06 (EP);
A61P17/02 (EP);
A61P17/06 (EP);
A61P19/00 (EP);
A61P25/00 (EP);
A61P29/00 (EP);
A61P3/04 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P35/00 (EP);
A61P37/04 (EP);
A61P43/00 (EP);
A61P9/00 (EP);
A61P9/02 (EP)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/36] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | VERWENDUNG VONHMGB-FRAGMENTEN ALS ENTZÜNDUNGSHEMMENDE MITTEL | [2005/36] | English: | USE OF HMGB FRAGMENTS AS ANTI-INFLAMMATORY AGENTS | [2005/36] | French: | UTILISATION DE FRAGMENTS HMGB EN TANT QU'AGENTS ANTI-INFLAMMATOIRES | [2005/36] | Entry into regional phase | 16.06.2005 | National basic fee paid | 16.06.2005 | Search fee paid | 16.06.2005 | Designation fee(s) paid | 16.06.2005 | Examination fee paid | Examination procedure | 15.06.2005 | Amendment by applicant (claims and/or description) | 16.06.2005 | Examination requested [2005/36] | 18.08.2008 | Despatch of a communication from the examining division (Time limit: M04) | 30.12.2008 | Application deemed to be withdrawn, date of legal effect [2009/25] | 03.02.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/25] | Fees paid | Renewal fee | 29.11.2005 | Renewal fee patent year 03 | 27.11.2006 | Renewal fee patent year 04 | 27.11.2007 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.11.2008 | 06   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]EP1033401 (GENSET SA [FR])[X] 13; | [X] - ROGALLA P ET AL, "Mapping and molecular characterization of five HMG1-related DNA sequences", CYTOGENETICS AND CELL GENETICS, (1998), vol. 83, no. 1-2, ISSN 0301-0171, pages 124 - 129, XP009063822 [X] 1 * abstract * * page 124, column R, paragraph 2 * * page 126, column R, line 12 - page 127, column R, line 10; figure 3 * DOI: http://dx.doi.org/10.1159/000015147 | [X] - "Human secreted protein, SEQ ID NO: 7904.", Geneseq, (20001006), Database accession no. AAG03823, URL: EBI, XP002373264 [X] 11-14 * Geneseq accession number AAG03823 is 100% identical with SEQ ID No:4 of the present application over the entire length of SEQ ID No:4. AAG03823 is identical to SEQ ID No:7904 of EP1033401 * | [A] - DAILEY LISA ET AL, "Coevolution of HMG domains and homeodomains and the generation of transcriptional regulation by Sox/POU complexes", JOURNAL OF CELLULAR PHYSIOLOGY, (200103), vol. 186, no. 3, ISSN 0021-9541, pages 315 - 328, XP002373261 [A] 1,7,11-15,25,27 * page 316, column R, paragraph 2; figure 2 * DOI: http://dx.doi.org/10.1002/1097-4652(2001)9999:9999<000::AID-JCP1046>3.0.CO;2-Y | [T] - YANG HUAN ET AL, "Reversing established sepsis with antagonists of endogenous high-mobility group box 1.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (20040106), vol. 101, no. 1, ISSN 0027-8424, pages 296 - 301, XP002373262 [T] 1,7,11-15,25,27 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.2434651100 | International search | [X] - WANG ET AL., "HMG-1 as a late mediator of endotoxin lethality in mice", SCIENCE, (19990709), vol. 285, no. 5425, pages 248 - 251, XP002940163 DOI: http://dx.doi.org/10.1126/science.285.5425.248 | [X] - ANDERSSON ET AL., "High mobility group 1 protein (HMG-1) stimulates proinföammatory cytokine synthesis in human monocytes", J. EXP. MED., (20000821), vol. 192, no. 4, pages 565 - 570, XP002233473 DOI: http://dx.doi.org/10.1084/jem.192.4.565 | [X] - ABRAHAM ET AL., "Cutting edge: HMG-1 as a mediator of acute lung inflammation", J. IMMUNOL., (20000915), vol. 165, no. 6, pages 2950 - 2954, XP002982921 |